Moxeza Ophthalmic Drops, Solution 0.5pct Drug Medication Dosage Information
show timeout overlay link

Your Session Is About to Expire

This online session is about to expire due to inactivity. Click Continue to return to page.

  • myWeekly Ad

MOXEZA: Ophthalmic drops, solution (0.5%)

Also see:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics

Visit Drug Summary Page
Drug Image file default-drug-image.png
MOXEZA 0.5% Ophthalmic Soln

What is this Medicine?

MOXIFLOXACIN (mox i FLOX a sin) is a quinolone antibiotic. It is used to treat bacterial eye infections.

CVS Pharmacy Patient Statistics for MOXEZA: Ophthalmic drops, solution(0.5%)
Generic vs. Brand Name Usage*
*Brand contains same active ingredient but may not represent FDA-approved generic equivalent
Usage By Strength
In-Depth Information

MOXEZA 0.5% Ophthalmic Solution

NDC: 000650006
  • Prescription Required
  • Not a Controlled Drug
    (CSA Schedule)
  • FDA Approved




FDA approved for the following conditions:
Chlamydial Conjunctivitis, Bacterial Conjunctivitis

Storage Information
Store between 36 to 77 degrees F
MOXEZA 0.5% Ophthalmic Solution

Reported Side Effects for MOXEZA 0.5% Ophthalmic Solution

Retinal Detachment Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Skin Rash Incidence:
0.1-4.0%*
Severity: MILD
Onset: EARLY
Infection Incidence:
0.1-4.0%*
Severity: MILD
Onset: DELAYED
Visual Impairment Incidence:
1.0-6.0%*
Severity: SEVERE
Onset: EARLY
Rhinitis Incidence:
1.0-4.0%*
Severity: MILD
Onset: EARLY
Eye Irritation Incidence:
1.0-6.0%*
Severity: MILD
Onset: RAPID
Bleeding Within The Eye Incidence:
1.0-6.0%*
Severity: SEVERE
Onset: DELAYED
Secretion Of Tears Incidence:
1.0-6.0%*
Severity: MILD
Onset: EARLY
Engorgement With Blood Incidence:
1.0-6.0%*
Severity: MODERATE
Onset: DELAYED
Conjunctivitis Incidence:
1.0-6.0%*
Severity: MODERATE
Onset: DELAYED
Cough Incidence:
1.0-4.0%*
Severity: MILD
Onset: DELAYED
Fever Incidence:
1.0-4.0%*
Severity: MILD
Onset: EARLY
Dry Eyes Incidence:
1.0-6.0%*
Severity: MILD
Onset: EARLY
Eye Inflammatoin Incidence:
1.0-6.0%*
Severity: SEVERE
Onset: DELAYED
Eye Pain Incidence:
1.0-6.0%*
Severity: MILD
Onset: EARLY
Sore Throat Incidence:
1.0-4.0%*
Severity: MILD
Onset: DELAYED
Itchy Eyes Incidence:
1.0-6.0%*
Severity: MILD
Onset: RAPID
*This is an approximate aggregated range of reported side effects from clinical studies performed on this drug. Your experience with this drug may be different.
Pregnancy & Lactation Information
FIRST Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

SECOND Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

THIRD Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

Lactation

Compatible - This drug is generally safe to take by nursing mothers.


Learning More About
Visit the Drug Summary page where you can:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics
Learn More
Patient Experiences with MOXEZA

We want to help you stay educated about the medications you are taking. View other
patient's observations and share your own.

Be sure to consult your health care provider before taking any medications. Other
patient's comments should not be considered medical advice or health care provider
recommendations.